A Randomized Double-Blind Placebo-Controlled Parallel-Group Study Conducted Under In-House Blinding Conditions of MK0633 in Patients With COPD.
Phase of Trial: Phase II
Latest Information Update: 05 Oct 2013
At a glance
- Drugs Setileuton (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 12 May 2009 Actual patient number changed from 380 to 266 as reported by ClinicalTrials.gov.
- 14 Apr 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Apr 2009 Actual patient number (380) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History